Deputy HHS Secretary Jim O'Neill says the Trump administration doesn't support CHAI, an effort by OpenAI, Mayo Clinic, and others to vet AI tools for healthcare
AI is transforming care. Hospitals are adopting high-tech systems to improve diagnoses and recommend treatments, but there's little formal regulation.
Context & Ripple Effects
Healthcare AI adoption had already outpaced consistent oversight: earlier reporting found hospitals using diagnosis systems that clinicians sometimes felt pressure to follow despite flaws clinicians' concerns about flawed diagnostic algorithms. This administration's refusal to back CHAI makes voluntary, sector-led evaluation a more consequential part of the deployment environment.
The stance matters because CHAI brings together an AI supplier and a major provider organization around healthcare-tool vetting, while HHS is signaling it does not want that work to become a centralized federal gatekeeper.
First-order effects
- CHAI loses potential political backing from HHS, limiting its ability to present coalition vetting as aligned with federal policy.
- Hospitals and AI vendors deploying clinical tools must continue to rely on their own validation, procurement, and governance processes rather than expect CHAI endorsement to carry federal weight.
Second-order effects
- Competing healthcare-AI developers may differentiate through provider partnerships, privacy assurances, and internal evidence-generation rather than a common government-supported certification path.
- Provider systems face greater pressure to define operational safeguards and accountability themselves, especially where clinicians are asked to use algorithmic recommendations.
Third-order effects
- If federal policy continues to favor adoption without a centralized AI-specific regulator, healthcare AI governance is likely to remain fragmented across providers, vendors, and existing health regulators.
- That fragmentation could make locally demonstrated clinical utility and procurement standards more influential than a single national seal, though the effect will depend on whether agencies later set enforceable requirements.
The trend: Healthcare AI is moving toward deployment-led governance, with provider and vendor controls filling gaps left by resistance to centralized AI regulation.